Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|April 25, 2009
Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectivesFrancesca Merchionne, Franco Dammacco
Critical Reviews in Oncology/Hematology|November 2, 2010
Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single centerFrancesca Merchionne, Pasquale Procaccio, Franco Dammacco
Clinical and Experimental Medicine|September 16, 2008
Long-term survival in multiple myeloma: a single-center experienceFrancesca Merchionne, Pasquale Procaccio, Franco Dammacco
Mini Reviews in Medicinal Chemistry|March 22, 2005
Antiangiogenesis by chemotherapeutic agentsDomenico Ribatti, Angelo Vacca, Francesca Merchionne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: implication for peptide-based active immunotherapyFederico Perosa, Elvira Favoino, Chiara Vicenti, et al.
Leukemia Research|April 28, 2004
Angiogenesis in acute and chronic lymphocytic leukemiaStefano Molica, Angelo Vacca, Domenico Levato, et al.
Haematologica|August 6, 2002
Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myelomaRoberto Ria, Angelo Vacca, Domenico Ribatti, et al.
Cancer Letters|April 10, 2004
CXCR3-binding chemokines in multiple myelomaAntonio Pellegrino, Francesco Antonaci, Francesca Russo, et al.
Journal of Hematotherapy & Stem Cell Research|February 16, 2002
Docetaxel versus paclitaxel for antiangiogenesisAngelo Vacca, Domenico Ribatti, Monica Iurlaro, et al.
Leukemia Research|December 3, 2014
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysisFrancesca Merchionne, Giovanni Quintana, Francesco Gaudio, et al.
Pageof 2